Cost-effectiveness of cancer drugs is questioned
The widespread use of expensive cancer drugs to prolong patients’ lives by just weeks or months was called into question by an article published in the Journal of the National Cancer Institute. But while some policy experts consider the rationing of healthcare resources inevitable in the quest to control medical spending, many Americans have long resisted putting the collective fiscal good over their individual health.
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CHS Hacked, 4.5M Patient Records Compromised
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- Business Roundup: M&A Activity Down Slightly in First Half of 2014
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Large Employers Trimming Healthcare Spending